Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.980
-0.020 (-1.00%)
Jun 17, 2025, 12:11 PM - Market open
Inovio Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$9.75
Upside
+392.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $5 | Hold | Reiterates | $5 | +152.53% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $15 → $13 | Buy | Maintains | $15 → $13 | +556.57% | May 14, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +152.53% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $3 | Hold | Reiterates | $3 | +51.52% | Mar 19, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +809.09% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +51.52% | Jan 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +809.09% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $5 | Hold | Maintains | $12 → $5 | +152.53% | Nov 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $33 → $15 | Buy | Maintains | $33 → $15 | +657.58% | Nov 18, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +203.03% | Nov 15, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +253.54% | Oct 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 → $33 | Buy | Maintains | $40 → $33 | +1,566.67% | Aug 12, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $8 | Hold | Maintains | $11 → $8 | +304.04% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $15 | Hold | Reiterates | $15 | +657.58% | Jul 15, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $20 | Buy | Initiates | $20 | +910.10% | May 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 | Buy | Maintains | $40 | +1,920.20% | Mar 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.